DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R.
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.
Arthritis Rheum 2008; 58: 1299-1309
We do not assume any responsibility for the contents of the web pages of other providers.